Genmab A/S (CPH:GMAB)
Denmark
· Delayed Price · Currency is DKK 1,358.00
-5.50 (-0.40%)
Jul 9, 2025, 3:00 PM CET
Genmab Market Cap
Genmab has a market cap or net worth of 83.86 billion as of July 9, 2025. Its market cap has decreased by -27.05% in one year.
Market Cap
83.86B
Enterprise Value
62.58B
Revenue
22.30B
Ranking
n/a
PE Ratio
10.76
Stock Price
1,358.00
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 83.86B, an increase of 2,176.17%. That is a compound annual growth rate of 13.47%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,997.35B |
| Coloplast | 136.59B |
| Demant | 57.00B |
| ALK-Abelló | 42.18B |
| H. Lundbeck | 34.17B |
| Zealand Pharma | 26.62B |
| Ambu A/S | 26.12B |
| GN Store Nord | 14.43B |